EL.En. S.p.A
EL.En. S.p.A. engages in the production, research and development, distribution, and sale of laser systems in Italy, rest of Europe, and internationally. The company offers laser systems for the medical sector and the industrial sector. It also develops, manufactures, and markets products, including solid-state laser, semiconductor laser, active fiber laser, dye laser, and CO2 laser, as well as r… Read more
EL.En. S.p.A (ELEAF) - Net Assets
Latest net assets as of September 2025: $0.00 USD
Based on the latest financial reports, EL.En. S.p.A (ELEAF) has net assets worth $0.00 USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($177.25 Million) and total liabilities ($177.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $0.00 |
| % of Total Assets | 0% |
| Annual Growth Rate | 9.92% |
| 5-Year Change | 70.69% |
| 10-Year Change | N/A |
| Growth Volatility | 7.34 |
EL.En. S.p.A - Net Assets Trend (2016–2024)
This chart illustrates how EL.En. S.p.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EL.En. S.p.A (2016–2024)
The table below shows the annual net assets of EL.En. S.p.A from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $410.80 Million | +9.41% |
| 2023-12-31 | $375.46 Million | +5.28% |
| 2022-12-31 | $356.64 Million | +23.96% |
| 2021-12-31 | $287.70 Million | +19.54% |
| 2020-12-31 | $240.66 Million | +0.01% |
| 2019-12-31 | $240.63 Million | +9.76% |
| 2018-12-31 | $219.24 Million | +7.31% |
| 2017-12-31 | $204.30 Million | +6.02% |
| 2016-12-31 | $192.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to EL.En. S.p.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 52.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $211.05 Million | 54.81% |
| Other Components | $173.97 Million | 45.19% |
| Total Equity | $385.02 Million | 100.00% |
EL.En. S.p.A Competitors by Market Cap
The table below lists competitors of EL.En. S.p.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Episil Holding
TWO:3707
|
$415.29 Million |
|
YUNFENG FINANCIAL GRP LTD
F:MNA1
|
$415.43 Million |
|
International Money Express Inc
NASDAQ:IMXI
|
$415.51 Million |
|
Cuscal Limited
F:Y49
|
$415.52 Million |
|
Luyin Investment Group Co Ltd
SHG:600784
|
$414.99 Million |
|
Westaim Corp
V:WED
|
$414.98 Million |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
$414.89 Million |
|
SANLORENZO IN SIGLA SL
F:6SZA
|
$414.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EL.En. S.p.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 346,030,481 to 385,020,585, a change of 38,990,104 (11.3%).
- Net income of 51,613,294 contributed positively to equity growth.
- Dividend payments of 17,051,406 reduced retained earnings.
- Share repurchases of 5,274,748 reduced equity.
- New share issuances of 754,245 increased equity.
- Other factors increased equity by 8,948,719.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $51.61 Million | +13.41% |
| Dividends Paid | $17.05 Million | -4.43% |
| Share Repurchases | $5.27 Million | -1.37% |
| Share Issuances | $754.25K | +0.2% |
| Other Changes | $8.95 Million | +2.32% |
| Total Change | $- | 11.27% |
Book Value vs Market Value Analysis
This analysis compares EL.En. S.p.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.97x to 2.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $2.47 | $9.80 | x |
| 2018-12-31 | $2.60 | $9.80 | x |
| 2019-12-31 | $3.08 | $9.80 | x |
| 2020-12-31 | $2.87 | $9.80 | x |
| 2021-12-31 | $3.38 | $9.80 | x |
| 2022-12-31 | $4.01 | $9.80 | x |
| 2023-12-31 | $4.33 | $9.80 | x |
| 2024-12-31 | $4.81 | $9.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EL.En. S.p.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.41%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.12%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 1.92x
- Recent ROE (13.41%) is above the historical average (13.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 22.22% | 15.86% | 0.85x | 1.65x | $22.22 Million |
| 2017 | 8.21% | 5.10% | 0.91x | 1.76x | $-3.40 Million |
| 2018 | 8.37% | 4.83% | 0.97x | 1.79x | $-3.27 Million |
| 2019 | 10.81% | 6.49% | 0.94x | 1.77x | $1.95 Million |
| 2020 | 8.99% | 4.96% | 0.87x | 2.09x | $-2.29 Million |
| 2021 | 16.87% | 7.95% | 0.88x | 2.42x | $18.50 Million |
| 2022 | 17.22% | 8.18% | 0.92x | 2.30x | $23.11 Million |
| 2023 | 13.94% | 8.37% | 0.80x | 2.08x | $13.64 Million |
| 2024 | 13.41% | 9.12% | 0.76x | 1.92x | $13.11 Million |
Industry Comparison
This section compares EL.En. S.p.A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $539,803,485
- Average return on equity (ROE) among peers: -52.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EL.En. S.p.A (ELEAF) | $0.00 | 22.22% | N/A | $415.27 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-7.40 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $3.67 Billion | 38.07% | 1.09x | $190.05 Billion |
| Acarix AB (publ) (ACIXF) | $1.44 Million | -102.09% | 0.28x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $2.76 Million | -21.69% | 0.89x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $9.28 Million | -68.70% | 0.12x | $2.76 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $911.62 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $11.89 Million | -17.74% | 0.30x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $456.18K | -277.12% | 2.12x | $10.62 Million |